Clinical Trial Detail

NCT ID NCT02321501
Title Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Ceritinib + Everolimus

Age Groups: adult senior

Additional content available in CKB BOOST